Last reviewed · How we verify

NCT04796519

Comparison of Balance and Fall Risk in Unilateral and Bilateral Total Knee Arthroplasty

Completed NA Last updated 15 March 2021
What this trial tests

NA trial testing Total knee arthroplasty in Knee Arthropathy in 45 participants. Completed in 10 October 2020.

Timeline
10 April 2019
Primary endpoint
1 July 2020
10 October 2020

Quick facts

Lead sponsorPamukkale University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment45
Start date10 April 2019
Primary completion1 July 2020
Estimated completion10 October 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Pamukkale University

Who can join

Adults 46 to 82, any sex, with Knee Arthropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Static or dynamic postural control cannot be fully restored in patients with Total Knee Arthroplasty (TKA). Moreover, deficits in balance and postural control may still be present in both extremity after TKA. However, the contralateral knee OA grade, asymmetrical gait pattern, and postural sways still remain a risk factor for balance deficits and falls. Based on this rationale, the aim of this study is to evaluate the balance and fall risk before and after TKA in patients who suffered from bilateral knee osteoarthritis and to clarify the balance and fall risk difference between unilateral and bilateral TKA patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Total knee arthroplasty

Trials testing the same drug.

Other recruiting trials for Knee Arthropathy

Currently open trials in the same condition.

Other Pamukkale University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04796519.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing